Molbio Diagnostics IPO Subscribed 1.22 Times by Day 2 with Positive Listing Outlook
Molbio Diagnostics' IPO, priced between Rs 768 and Rs 807 per share, opened on August 10 and will close on August 12, 2026. The issue includes a Rs 200 crore fresh equity offering and an offer for sale of 91.66 lakh shares. By Day 2, the IPO was subscribed 1.22 times overall, with strong demand from retail, non-institutional, and employee categories. The grey market premium suggests a potential listing price around Rs 930-935, indicating possible listing gains. Proceeds will fund R&D, infrastructure, and general corporate purposes.
First-hand measurement across 11 sources
We measured how 11 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (59/100). Lens Score 42/100.
Outlets measured: freepressjournal, mint, economictimes, indiatoday, news18, businessstandard, businessstandard, mint, and 3 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 9 Aug, 10:15 am. Other outlets followed.